These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 15178355)

  • 1. Pharmacological characterization of dihydromorphine, 6-acetyldihydromorphine and dihydroheroin analgesia and their differentiation from morphine.
    Gilbert AK; Hosztafi S; Mahurter L; Pasternak GW
    Eur J Pharmacol; 2004 May; 492(2-3):123-30. PubMed ID: 15178355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel receptor mechanisms for heroin and morphine-6 beta-glucuronide analgesia.
    Rossi GC; Brown GP; Leventhal L; Yang K; Pasternak GW
    Neurosci Lett; 1996 Sep; 216(1):1-4. PubMed ID: 8892377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense mapping of MOR-1 in rats: distinguishing between morphine and morphine-6beta-glucuronide antinociception.
    Rossi GC; Leventhal L; Pan YX; Cole J; Su W; Bodnar RJ; Pasternak GW
    J Pharmacol Exp Ther; 1997 Apr; 281(1):109-14. PubMed ID: 9103486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronopharmacology of analgesic effect and its tolerance induced by morphine in mice.
    Yoshida M; Ohdo S; Takane H; Tomiyoshi Y; Matsuo A; Yukawa E; Higuchi S
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1200-5. PubMed ID: 12626644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Codeine and 6-acetylcodeine analgesia in mice.
    Milo S; Ansonoff M; King M; Rossi GC; Zuckerman A; Pintar J; Pasternak GW
    Cell Mol Neurobiol; 2006; 26(4-6):1011-9. PubMed ID: 16868817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No heroin or morphine 6beta-glucuronide analgesia in mu-opioid receptor knockout mice.
    Kitanaka N; Sora I; Kinsey S; Zeng Z; Uhl GR
    Eur J Pharmacol; 1998 Aug; 355(1):R1-3. PubMed ID: 9754945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of mu analgesics: from patients to genes.
    Pasternak GW
    Neuroscientist; 2001 Jun; 7(3):220-31. PubMed ID: 11499401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain.
    Rashid MH; Inoue M; Toda K; Ueda H
    J Pharmacol Exp Ther; 2004 Apr; 309(1):380-7. PubMed ID: 14718584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats.
    Rossi GC; Standifer KM; Pasternak GW
    Neurosci Lett; 1995 Sep; 198(2):99-102. PubMed ID: 8592651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in tolerance to anti-hyperalgesic effects between chronic treatment with morphine and fentanyl under a state of pain.
    Imai S; Narita M; Hashimoto S; Nakamura A; Miyoshi K; Nozaki H; Hareyama N; Takagi T; Suzuki M; Narita M; Suzuki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Nov; 26(5-6):183-92. PubMed ID: 17240843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy between mu opioid ligands: evidence for functional interactions among mu opioid receptor subtypes.
    Bolan EA; Tallarida RJ; Pasternak GW
    J Pharmacol Exp Ther; 2002 Nov; 303(2):557-62. PubMed ID: 12388636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGS14 prevents morphine from internalizing Mu-opioid receptors in periaqueductal gray neurons.
    Rodríguez-Muñoz M; de la Torre-Madrid E; Gaitán G; Sánchez-Blázquez P; Garzón J
    Cell Signal; 2007 Dec; 19(12):2558-71. PubMed ID: 17825524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential blockade of opioid analgesia by antisense oligodeoxynucleotides directed against various G protein alpha subunits.
    Standifer KM; Rossi GC; Pasternak GW
    Mol Pharmacol; 1996 Aug; 50(2):293-8. PubMed ID: 8700136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of opioid tolerance by antisense oligodeoxynucleotides targeting neurogranin.
    Tang L; Shukla PK; Wang ZJ
    Eur J Pharmacol; 2006 Aug; 542(1-3):106-7. PubMed ID: 16797003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1.
    Schuller AG; King MA; Zhang J; Bolan E; Pan YX; Morgan DJ; Chang A; Czick ME; Unterwald EM; Pasternak GW; Pintar JE
    Nat Neurosci; 1999 Feb; 2(2):151-6. PubMed ID: 10195199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
    Juni A; Klein G; Kest B
    Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-Methoxymetopon, a very potent mu-opioid receptor-selective analgesic with an unusual pharmacological profile.
    King MA; Su W; Nielan CL; Chang AH; Schütz J; Schmidhammer H; Pasternak GW
    Eur J Pharmacol; 2003 Jan; 459(2-3):203-9. PubMed ID: 12524147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine-6beta-glucuronide-induced hyperphagia: characterization of opioid action by selective antagonists and antisense mapping in rats.
    Leventhal L; Silva RM; Rossi GC; Pasternak GW; Bodnar RJ
    J Pharmacol Exp Ther; 1998 Nov; 287(2):538-44. PubMed ID: 9808678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.
    Narita M; Suzuki M; Narita M; Niikura K; Nakamura A; Miyatake M; Yajima Y; Suzuki T
    Neuroscience; 2006; 138(2):609-19. PubMed ID: 16417975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.
    Mathews JL; Peng X; Xiong W; Zhang A; Negus SS; Neumeyer JL; Bidlack JM
    J Pharmacol Exp Ther; 2005 Nov; 315(2):821-7. PubMed ID: 16076937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.